10x Genomics, Inc. TXG Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s return on equity?
- 10x Genomics, Inc. (TXG) reported return on equity of -3% in Q1 2026.
- How has 10x Genomics, Inc.'s return on equity changed year-over-year?
- 10x Genomics, Inc.'s return on equity increased by 86.5% year-over-year, from -22% to -3%.
- What is the long-term trend for 10x Genomics, Inc.'s return on equity?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s return on equity has grown at a -42.7% compound annual growth rate (CAGR), from -93.6% to -5.8%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.